Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Absci Corporation - Common Stock
(NQ:
ABSI
)
3.740
+0.130 (+3.60%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Absci Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference
December 16, 2025
From
Absci Corporation
Via
GlobeNewswire
Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization
December 11, 2025
From
Absci Corporation
Via
GlobeNewswire
Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research
December 10, 2025
From
Absci Corporation
Via
GlobeNewswire
Earnings Scheduled For November 12, 2025
↗
November 12, 2025
Via
Benzinga
Absci's Earnings: A Preview
↗
August 11, 2025
Via
Benzinga
Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia
December 04, 2025
From
Absci Corporation
Via
GlobeNewswire
10 AI Stocks Worth Buying Right Now
↗
December 04, 2025
Building an artificial intelligence (AI) portfolio means looking beyond the obvious megacap names.
Via
The Motley Fool
Topics
Artificial Intelligence
Beyond the Hype: AI’s Quiet Revolution in Niche Sectors Reshapes Industries from Medicine to Agriculture
December 01, 2025
Artificial intelligence, often spotlighted for its advancements in mainstream applications like conversational agents and autonomous vehicles, is quietly orchestrating a profound transformation across...
Via
TokenRing AI
Topics
Artificial Intelligence
Economy
Emissions
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
November 13, 2025
Via
Benzinga
Absci (ABSI) Q3 2025 Earnings Call Transcript
↗
November 13, 2025
Absci (ABSI) Q3 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Artificial Intelligence
Earnings
Ardent Health, KinderCare Learning, Ibotta And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
November 13, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
November 13, 2025
Via
Benzinga
Wednesday's after hours session: top gainers and losers
↗
November 12, 2025
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via
Chartmill
Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results
November 12, 2025
From
Absci Corporation
Via
GlobeNewswire
Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025
October 29, 2025
From
Absci Corporation
Via
GlobeNewswire
Absci to Participate in Upcoming Investor Conferences
October 27, 2025
From
Absci Corporation
Via
GlobeNewswire
Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial
October 15, 2025
From
Absci Corporation
Via
GlobeNewswire
Absci's AI Revolution: A New Era for Drug Discovery or a Rocky Road Ahead?
October 13, 2025
Absci (NASDAQ: ABSI), a pioneer in AI-driven drug discovery, is making significant strides with its "Integrated Drug Creation™ Platform," promising to revolutionize how new medicines are brought to...
Via
MarketMinute
Topics
Artificial Intelligence
2 Reasons Absci Could Be the Future of AI Biotech, and 1 Risk
↗
October 13, 2025
Absci's AI drug development platform is compelling, and its pipeline is promising...but can the company overcome execution hurdles to live up to analyst hype?
Via
MarketBeat
Topics
Artificial Intelligence
Dell, Select Medical, Century Aluminum And Other Big Stocks Moving Higher On Wednesday
↗
October 08, 2025
Via
Benzinga
This Synopsys Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday
↗
October 02, 2025
Via
Benzinga
AI Revolutionizes Professional Services: A New Era for Doctors, Lawyers, and Consultants
October 01, 2025
As of October 1, 2025, Artificial Intelligence (AI) has transcended its nascent stages, becoming an indispensable force in high-value professional tasks across medicine, law, and consulting. This...
Via
MarketMinute
Topics
Artificial Intelligence
Absci Boosts AI-Powered Drug Discovery With Oracle And AMD Collaboration
↗
September 11, 2025
Absci teams up with Oracle and AMD to enhance AI-driven drug discovery using high-performance GPUs.
Via
Benzinga
Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD
September 11, 2025
Performance and scalability of Oracle Cloud Infrastructure AI infrastructure enables Absci to accelerate biologics design cycles and reduce costs
From
Absci Corporation; Oracle; AMD
Via
GlobeNewswire
Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg
August 25, 2025
World-renowned experts will guide the clinical development of ABS-201, a therapeutic antibody entering clinical trials for the treatment of androgenetic alopecia.
From
Absci Corporation
Via
GlobeNewswire
Absci to Participate in Upcoming Investor Conferences
August 20, 2025
From
Absci Corporation
Via
GlobeNewswire
Absci Sales Fall 54 Percent
↗
August 12, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
Absci Corp (NASDAQ:ABSI) Q2 2025 Earnings: Revenue Miss Sparks Market Selloff
↗
August 12, 2025
Absci Corp (ABSI) Q2 2025 earnings miss revenue estimates at $0.59M vs. $1.46M, EPS -$0.24. Stock drops 5% post-report despite strong cash position and pipeline progress.
Via
Chartmill
Topics
Earnings
Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results
August 12, 2025
From
Absci Corporation
Via
GlobeNewswire
Earnings Scheduled For August 12, 2025
↗
August 12, 2025
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
